Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FALSE CLAIMS ACT—9th Cir.: Adventist not barred from suing over Section 340B violations via FCA qui tam action
    • ADMINISTRATION OF FDC ACT—NOTICES: Bulk manufacturer of controlled substances application; Pisgah Laboratories Inc
    • ADMINISTRATION OF FDC ACT—NOTICES: Bulk manufacturer of controlled substances application; Stepan Company
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Clinic’s Medicare billing reactivation date upheld by ALJ
    • EXPERT INSIGHTS—OIG's managed care compliance roadmap: Key risk areas for Medicare Advantage
    • FRAUD AND ABUSE—Trump signs E.O., formally launches task force to eliminate federal benefit fraud
    • GENERAL HEALTH CARE NEWS—N.D. Ill.: ECPA, other claims against utilizer of website analytics will proceed
    • HEALTH CARE COMPLIANCE NEWS—OIG Work Plan updates for February 2026
    • MEDICAID—D. Md.: Negligence, fiduciary duty, and Section 1983 claims fail again in Medicaid reimbursement dispute
    • MEDICAL DEVICES—PROPOSED RULES: Restricted sale, distribution, and use of sunlamp products proposal withdrawn
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, ADMINISTRATION OF FDC ACT—NOTICES: Bulk manufacturer of controlled substances application; Pisgah Laboratories Inc, (Mar 18, 2026)

    By WK Editorial Staff

    No other activities for the drug codes are authorized for the registration.

    Pisgah Laboratories Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). The company plans to bulk manufacture listed control ...

    By WK Editorial Staff

    No other activities for the drug codes are authorized for the registration.

    Pisgah Laboratories Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). The company plans to bulk manufacture listed controlled substances in bulk for internal research purposes and distribution to its customers (Notice, 91 Fed. Reg. 12446 (Mar. 13, 2026)).

    Dates. Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 12, 2026.

    FederalRegisterIssuances: Notices FDCActNews ControlledNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use